Ono Pharmaceutical Co., Ltd. Logo

The 2021 Golden Ticket Program is in Partnership with Ono Pharmaceutical Co., Ltd. (ONO)

Ono Pharmaceutical Co., Ltd. (ONO) is inviting you to apply for the 2021 MBC BioLabs Golden Ticket. The company will award one promising start-up company with a year of free lab space (and more!) at MBC BioLabs. ONO is keen to see emerging innovations in the life science field, which would have potential synergy with its current and future R&D activities.

Here’s what you can expect with an ONO – MBC BioLabs Golden Ticket award:

  • One-year FREE lab space at MBC BioLabs
  • Access to the shared amenities and services provided at MBC BioLabs
  • ONO’s R&D scientists, business leaders and global network partners

To apply, upload your non-confidential company presentation at MBCBioLabs.com/golden-ticket by May 7th, 2021. Once submitted, your company’s proposal will be reviewed by ONO’s internal committee and finalist companies will be notified and invited to present in early end of June. Winners will be notified soon thereafter and presented with awards.

Use the form below to apply by submitting your information and non-confidential deck – DEADLINE FOR APPLICATION IS MAY 7TH!

About MBC BioLabs

Learn More About MBC BioLabs

Rent a Bench. Change the World.

We’ve Helped 200 Companies Raise $4.75B In Funding.

Talk about enabling awesome.

MBC BioLabs has helped 200 companies raise an average of $24.2M, for a total of $4.75B raised! When we say we enable awesome, we mean it. MBC BioLabs gives life science innovators and entrepreneurs the facilities and equipment they need to be running experiments from day 1. Seriously. We even have a tradition of doing a champagne toast for every company that runs an experiment on its first day.

MBC BioLabs frees startups from the Catch 22 of needing funding to get data, and needing data to get funding by providing the space, the equipment, and the community. Click below to tour one of our labs!

About Ono Pharmaceutical Co., Ltd.

Ono Pharmaceutical Co., Ltd., headquartered in Osaka, is an R&D-oriented pharmaceutical company committed to creating innovative medicines in specific areas. Ono focuses its research on the oncology, immunology, neurology and specialty research with high medical needs as priority areas for discovery and development of innovative medicines. For further information, please visit the company’s website at https://www.ono-pharma.com/.

Learn More About Ono